The development of antimicrobial drug resistance among pathogenic bacteria and fungi is
one of the most significant health issues of the 21st century. Recently, advances in …

The treatment of invasive fungal infections remains challenging due to limitations in currently
available antifungal therapies including toxicity, interactions, restricted routes of …

Every year, Candida, Aspergillus, Cryptococcus and Pneumocystis infect an estimated two
million individuals worldwide. Most are immunocompromised or critically ill. Candida is the …

Practical Handbook of Microbiology, 4th edition provides basic, clear and concise
knowledge and practical information about working with microorganisms. Useful to anyone …

Invasive fungal infections (IFIs) represent a growing public concern for clinicians to manage
in many medical settings, with substantial associated morbidities and mortalities. Among …

The fungal microbiota is an important component of the human gut microbiome and may be
linked to gastrointestinal disease. In this study, the fungal microbiota of biopsy samples from …

Fungi, which can cause serious infections, results in more than 1.35 million deaths annually
throughout the world. Azole antifungal drugs which could inhibit the enzyme lanosterol 14α …

The world is constantly facing threats, including the emergence of new pathogens and
antibiotic resistance among extant pathogens, which is a matter of concern. Therefore, the …

Human nocardiosis may present as an acute or a chronic infection. Although a saprophyte
Nocardia spp are responsible for superficial skin infections, pulmonary infections, and …

The majority of opportunistic oral mucosal fungal infections are due to Candida albicans and
Aspergillus fumigatus species. Mucor and Cryptococcus also have a major role in causing …